HIV reaches generalized epidemic levels in 30 Russian regions

Russia detects HIV in 3% of men aged 30 to 50

HIV in Russia is no longer confined to the margins. Rospotrebnadzor has registered a generalized epidemic in 30 regions and has detected the bicho in 3% of men aged 30 to 50, an age group that until now fell outside the so-called traditional risk groups. In Kemerovo, Irkutsk and Sverdlovsk, more than 1% of pregnant women test positive. Half of those carrying the bicho receive therapy; around 600,000 people are living with HIV without treatment.

With that snapshot on the table, the conversation has split three ways. Some look at the healthcare system and the epidemiological registry. Others look at the messenger that broke the news. And a third group, small but very loud, claims the bicho does not exist: a thesis that does not survive clinical scrutiny and is best dealt with quickly, because everything else is built on top of it.

What the report says: 30 regions and two thirds via heterosenshetero transmission

The figure that breaks the mold is the route of transmission. Two thirds of new cases are linked to heterosenshetero contact. That dismantles the label of a problem concentrated in specific groups and is exactly what justifies the word epidemic. When most infections no longer depend on an identifiable behavior, contact tracing becomes harder and prevention campaigns have to speak to everyone, not to a leaflet handed out at one particular doorway.

The second element is where cases are detected. Most new cases are registered in medical institutions: routine tests, emergency rooms, admissions for any other cause. In plain language, diagnosis comes late. A positive result showing up in a workplace screening or a preoperative test means the patient had been carrying the bicho, unaware, for a long time.

The third point is the treatment funnel, and it is the costliest. Only half of those carrying the bicho receive the therapy they need. Every patient without a suppressed viral load is both a source of transmission and a hospital bill that gets paid ten years later, when opportunistic infections appear.

Kemerovo, Irkutsk and Sverdlovsk: why the 1% figure among pregnant women is the key number

Pregnant women's screening is the classic bellwether of any epidemic: it measures women who have reported no risk behavior, who took the test because protocol required it, not out of suspicion. When that group exceeds 1% in three different regions, the label "generalized" stops being rhetoric. That is where the threshold lies, and that is the headline nobody wants to give.

There is one detail that mars the story of surprise: the monitoring existed almost two decades ago. One participant recalls that as early as 2008, a negative HIV test was required for a multiple-entry visa to the Russian Federation. If the administrative permit had carried that requirement all along, today's finding would not describe a new bicho, but a registry that was slow to reveal what it already knew.

RNA copies per milliliter: what an HIV test actually measures

The claim circulates that no test exists and that it is all a deal. Clinical practice says otherwise. A laboratory does not stop at a positive or negative result: it quantifies the viral load in RNA copies per milliliter of plasma and measures CD4 lymphocytes. When treatment works, the viral load falls and CD4 counts rise. That correlation between viral suppression and immune recovery is what holds up the entire building, and it cannot be explained away by suggestion.

The chronology used to deny it does not help either: the HIV acronym dates from 1986 and the first publication on the bicho is from 1983, with a tiny sample. True. But between a paper with a single patient and a body of evidence with reproducible viral counts there is a distance, and that distance has been covered. Denialist theses, from the Perth Group onward, are not supported by evidence and have been rejected by the scientific community; propped up by the argument that correlation does not imply causation, they fail to explain why suppressing the bicho returns CD4 counts to normal.

Who spread the figure and why the messenger shifts the focus

The news was circulated by an account aligned with Ukraine and sharply critical of Russia, and much of the reaction stayed on the wrapping: if someone aligned with Ukraine publishes it, the figure must be propaganda. Skepticism about the framing is reasonable. Jumping to dismissing the number is not: the figures come from Rospotrebnadzor, not from the tweeter.

The other front is demographic. It is argued that the population of sub-Saharan Africa has multiplied while the apocalypse was being announced, and that such a rebuttal should set off every alarm. High mortality and high birth rates coexist without problem; a population can grow and suffer at the same time. It is not the silver bullet its defenders think it is.

---

If prevalence keeps rising in the 30-to-50 age group, the sensible expectation is that the next report will extend the list of regions and that pressure will fall on access to treatment, not on diagnosis. With one caveat that could shift the whole picture: any rate depends on how many people get tested, and in a country where half of those carrying the bicho go untreated, the denominator is always up for debate.